• Anesthesia and analgesia · Aug 2007

    Comparative Study

    A modified mid-femoral approach to the sciatic nerve block: a correlation between evoked motor response and sensory block.

    • Antoine Pianezza, Marie-Luce Gilbert, Vincent Minville, Daren Filsinger, Quentin Gobert, Alain Guérot, Régis Fuzier, and Olivier Fourcade.
    • Department of Anesthesiology and Intensive Care, University Hospital of Toulouse, University Paul Sabatier, Toulouse, France. a.pianezza@wanadoo.fr
    • Anesth. Analg. 2007 Aug 1;105(2):528-30.

    BackgroundThe lateral sciatic mid-femoral block (LSMF), proved to be reliable, safe, and effective on both branches of the sciatic nerve with a single injection. However, we do not know which component of the sciatic nerve (the tibial [T] or the common peroneal [CP]) produces a better success rate when performing a LSMF with a single injection technique. In this prospective study we compared the success rate of the T motor response with the CP motor response.MethodsNinety-five patients undergoing ankle or foot surgery were enrolled. Thirty milliliters of 0.475% ropivacaine was injected at the first evoked motor response, either T or CP, with a minimal intensity between 0.3 and 0.5 mA.ResultsSeventy-two patients were included in group T and 23 in group CP. The block was considered a success when a complete sensory block of the sciatic nerve was obtained. The success rate was 90% (65) for the T response and 70% (16) for the CP response (P < 0.05). Time to perform the block (CP: 4.5 +/- 3 min vs T: 4.5 +/- 4 min; P = NS) as well as sensory and motor onset times were not significantly different between groups. No complications were observed in either group.ConclusionWe conclude that the evoked motor response of the T branch is associated with a higher success rate than a CP response using the modified LSMF block.

      Pubmed     Full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.